Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco Marketplace
Launched by MIKHAIL N KOFFARNUS · Jan 22, 2024
Trial Information
Current as of September 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
After granting informed consent, participants will complete a baseline assessment session. This will be followed by an extended 9-week sampling period to acclimate participants to their randomly assigned experimental cigarette and allow any shifts in product consumption patterns to materialize. In the final week of this sampling period, participants will complete behavioral assessments and a series of assessments to assess the impact of potential regulatory environments relevant to our aims.
Experimental Tobacco Marketplace. In this procedure, participants will complete purchasing scenario...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 21 years old
- • Consume nicotine and/or tobacco products daily
- • Have no plans to quit nicotine/tobacco consumption or seek treatment in the subsequent 9 weeks
- • Read and understand English
- Exclusion Criteria:
About Mikhail N Koffarnus
Mikhail N. Koffarnus is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic interventions. With a strong background in clinical pharmacology and a commitment to rigorous scientific methodology, Koffarnus leads and oversees a diverse portfolio of clinical trials. His expertise encompasses the design, implementation, and management of studies that explore novel treatment options across various therapeutic areas. By fostering collaboration among multidisciplinary teams and prioritizing ethical standards, Mikhail N. Koffarnus aims to contribute significantly to the advancement of healthcare and the discovery of effective medical solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported